Molecular Imaging Insight - May 2008 - (Page 3)

BY L I S A F R AT T ADDITIONAL RESOURCES: Siemens MI University WHEN breast cancer Molecular Imaging Molecular imaging technology—speciﬁcally whole-body FDG-PET and PET/CT— has long been involved in guiding breast cancer treatment decisions. In fact, staging of breast cancer with FDG-PET has been approved by CMS for reimbursement for quite some time. Today, whole-body PET and PET/CT are fairly widely used and accepted in the staging and clinical management of breast cancer. However, there is currently no uniform clinical utilization of PET and PET/CT in breast cancer. Firm practice guidelines do not exist. In some cases, the technology might be over-used—but more frequently—utilization is much too low. MolecularImaging.net is the Right Choice May 2008 | Molecular Imaging Insight 3 http://www.mi-university.com http://MolecularImaging.net Table of Contents for the Digital Edition of Molecular Imaging Insight - May 2008Molecular Imaging Insight - May 2008ContentsNOPR: A Landmark StudyBreast Cancer: When Molecular Imaging is the Right ChoiceNOPR Delivers Evidence for Expanded PET Use in Oncology ImagingCan We Afford Not to Use FDG-PET?Pint-size Power: PET/CT and SPECT/CT in PediatricsPET/CT in EvolutionPET/CT & Next-Generation Radiation TherapyMR/PET: New Insights into Hybrid ImagingMolecular Imaging Insight - May 2008Molecular Imaging Insight - May 2008 - Molecular Imaging Insight - May 2008 (Page Cover1)Molecular Imaging Insight - May 2008 - Molecular Imaging Insight - May 2008 (Page Cover2)Molecular Imaging Insight - May 2008 - Contents (Page 1)Molecular Imaging Insight - May 2008 - NOPR: A Landmark Study (Page 2)Molecular Imaging Insight - May 2008 - Breast Cancer: When Molecular Imaging is the Right Choice (Page 3)Molecular Imaging Insight - May 2008 - Breast Cancer: When Molecular Imaging is the Right Choice (Page 4)Molecular Imaging Insight - May 2008 - Breast Cancer: When Molecular Imaging is the Right Choice (Page 5)Molecular Imaging Insight - May 2008 - NOPR Delivers Evidence for Expanded PET Use in Oncology Imaging (Page 6)Molecular Imaging Insight - May 2008 - NOPR Delivers Evidence for Expanded PET Use in Oncology Imaging (Page 7)Molecular Imaging Insight - May 2008 - Can We Afford Not to Use FDG-PET? (Page 8)Molecular Imaging Insight - May 2008 - Can We Afford Not to Use FDG-PET? (Page 9)Molecular Imaging Insight - May 2008 - Can We Afford Not to Use FDG-PET? (Page 10)Molecular Imaging Insight - May 2008 - Pint-size Power: PET/CT and SPECT/CT in Pediatrics (Page 11)Molecular Imaging Insight - May 2008 - Pint-size Power: PET/CT and SPECT/CT in Pediatrics (Page 12)Molecular Imaging Insight - May 2008 - Pint-size Power: PET/CT and SPECT/CT in Pediatrics (Page 13)Molecular Imaging Insight - May 2008 - PET/CT in Evolution (Page 14)Molecular Imaging Insight - May 2008 - PET/CT in Evolution (Page 15)Molecular Imaging Insight - May 2008 - PET/CT & Next-Generation Radiation Therapy (Page 16)Molecular Imaging Insight - May 2008 - PET/CT & Next-Generation Radiation Therapy (Page 17)Molecular Imaging Insight - May 2008 - PET/CT & Next-Generation Radiation Therapy (Page 18)Molecular Imaging Insight - May 2008 - PET/CT & Next-Generation Radiation Therapy (Page 19)Molecular Imaging Insight - May 2008 - MR/PET: New Insights into Hybrid Imaging (Page 20)Molecular Imaging Insight - May 2008 - MR/PET: New Insights into Hybrid Imaging (Page Cover3)Molecular Imaging Insight - May 2008 - MR/PET: New Insights into Hybrid Imaging (Page Cover4)http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.